Enhanced Stability of Polymeric Micelles Based on Postfunctionalized Poly(ethylene glycol)-b-poly(γ-propargyl l-glutamate): The Substituent Effect

One of the major obstacles that delay the clinical translation of polymeric micelle drug delivery systems is whether these self-assembled micelles can retain their integrity in blood following intravenous (IV) injection. The objective of this study was to evaluate the impact of core functionalizatio...

Full description

Bibliographic Details
Main Authors: Zhao, Xiaoyong (Contributor), Poon, Zhiyong (Contributor), Engler, Amanda C. (Contributor), Bonner, Daniel K. (Contributor), Hammond, Paula T (Author)
Other Authors: Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Hammond, Paula T. (Contributor)
Format: Article
Language:English
Published: American Chemical Society, 2013-07-10T16:23:50Z.
Subjects:
Online Access:Get fulltext
LEADER 03282 am a22003133u 4500
001 79570
042 |a dc 
100 1 0 |a Zhao, Xiaoyong  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Chemical Engineering  |e contributor 
100 1 0 |a Koch Institute for Integrative Cancer Research at MIT  |e contributor 
100 1 0 |a Zhao, Xiaoyong  |e contributor 
100 1 0 |a Poon, Zhiyong  |e contributor 
100 1 0 |a Engler, Amanda C.  |e contributor 
100 1 0 |a Bonner, Daniel K.  |e contributor 
100 1 0 |a Hammond, Paula T.  |e contributor 
700 1 0 |a Poon, Zhiyong  |e author 
700 1 0 |a Engler, Amanda C.  |e author 
700 1 0 |a Bonner, Daniel K.  |e author 
700 1 0 |a Hammond, Paula T  |e author 
245 0 0 |a Enhanced Stability of Polymeric Micelles Based on Postfunctionalized Poly(ethylene glycol)-b-poly(γ-propargyl l-glutamate): The Substituent Effect 
260 |b American Chemical Society,   |c 2013-07-10T16:23:50Z. 
856 |z Get fulltext  |u http://hdl.handle.net/1721.1/79570 
520 |a One of the major obstacles that delay the clinical translation of polymeric micelle drug delivery systems is whether these self-assembled micelles can retain their integrity in blood following intravenous (IV) injection. The objective of this study was to evaluate the impact of core functionalization on the thermodynamic and kinetic stability of polymeric micelles. The combination of ring-opening polymerization of N-carboxyanhydride (NCA) with highly efficient "click" coupling has enabled easy and quick access to a family of poly(ethylene glycol)-block-poly(γ-R-glutamate)s with exactly the same block lengths, for which the substituent "R" is tuned. The structures of these copolymers were carefully characterized by [superscript 1]H NMR, FT-IR, and GPC. When pyrene is used as the fluorescence probe, the critical micelle concentrations (CMCs) of these polymers were found to be in the range of 10[superscript -7]-10[superscript -6] M, which indicates good thermodynamic stability for the self-assembled micelles. The incorporation of polar side groups in the micelle core leads to high CMC values; however, micelles prepared from these copolymers are kinetically more stable in the presence of serum and upon SDS disturbance. It was also observed that these polymers could effectively encapsulate paclitaxel (PTX) as a model anticancer drug, and the micelles possessing better kinetic stability showed better suppression of the initial "burst" release and exhibited more sustained release of PTX. These PTX-loaded micelles exerted comparable cytotoxicity against HeLa cells as the clinically approved Cremophor PTX formulation, while the block copolymers showed much lower toxicity compared to the cremophor-ethanol mixture. The present work demonstrated that the PEG-b-PPLG can be a uniform block copolymer platform toward development of polymeric micelle delivery systems for different drugs through the facile modification of the PPLG block. 
520 |a National Institutes of Health (U.S.) (Grant R01-EB008082) 
520 |a United States. American Recovery and Reinvestment Act of 2009 
520 |a MIT-Harvard Center for Cancer Nanotechnology Excellence (CCNE Grant No. 1 U54 CA119349) 
546 |a en_US 
655 7 |a Article 
773 |t Biomacromolecules